Episurf Medical announced that the Medical Device Authority (MDA) in Malaysia has approved the company's implant technologies Episealer® Knee and Episealer® Talus for the Malaysian market. The approval follows a review process.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.22 SEK | -0.45% | +1.62% | -77.83% |
07-12 | Episurf Medical AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024 | CI |
04-24 | Episurf Medical Announces Distributor Agreement with Depuy-Synthes | CI |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-77.83% | 13.66M | |
+11.75% | 127B | |
+1.44% | 12.35B | |
-18.47% | 7.1B | |
+56.20% | 6.78B | |
+9.27% | 3.47B | |
-15.41% | 2.6B | |
-18.25% | 1.91B | |
-27.00% | 1.62B | |
-37.52% | 1.45B |
- Stock Market
- Equities
- EPIS B Stock
- News Episurf Medical AB
- Episurf Medical AB Implants Approves for Sale in Malaysia